As the COVID-19 pandemic reaches the end of its third year, and as Covid-related mortality in North America wanes, long Covid and its disabling symptoms are attracting more attention. Some individuals report symptoms lasting more than two years, and a subset report continuing disability. 

Long COVID – Into the Third Year, authored by Munich Re’s Dr. Tim Meagher, was recently published in the Journal of Insurance Medicine. The article provides an update on long Covid, with a particular focus on disease prevalence, disability and risk factors. It also discusses the longer-term outlook for individuals with long Covid.